|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| A61K 38/28 | |||
| A61K 31/155 | |||
| A61P 3/10 | |||
| A61P 3/04 |
| (11) | Number of the document | 2771024 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12775720.1 |
| Date of filing the European patent application | 2012-10-26 | |
| (97) | Date of publication of the European application | 2014-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/071271 |
| Date | 2012-10-26 |
| (87) | Number | WO 2013/060850 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 11187169 | 2011-10-28 | EP |
| (72) |
SILVESTRE, Louise, FR
SOUHAMI, Elisabeth, FR
WEI, Xiaodan, US
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (54) | TREATMENT PROTOCOL OF DIABETES TYPE 2 |
| TREATMENT PROTOCOL OF DIABETES TYPE 2 |